Emerging Inflammatory Biomarkers with Acute Stroke

Critical Care Nursing Clinics of North America

Volumn 21, Issue 4, 2009, Pages 493-505

  Wadas, Theresa M ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Biomarker; Cerebral; Inflammation; Ischemia; Stroke

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CYTOKINE; GELATINASE B; NERVE GROWTH FACTOR; PROTEIN S 100; REACTIVE OXYGEN METABOLITE; S 100 CALCIUM BINDING PROTEIN BETA SUBUNIT; S-100 CALCIUM-BINDING PROTEIN BETA SUBUNIT; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ACUTE DISEASE; BLOOD; EARLY DIAGNOSIS; HUMAN; IMMUNOLOGY; INFLAMMATION; METABOLISM; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; STROKE; TIME;

ACUTE DISEASE; BIOLOGICAL MARKERS; CYTOKINES; EARLY DIAGNOSIS; HUMANS; INFLAMMATION; MATRIX METALLOPROTEINASE 9; NATRIURETIC PEPTIDE, BRAIN; NERVE GROWTH FACTORS; PROGNOSIS; REACTIVE OXYGEN SPECIES; S100 PROTEINS; SENSITIVITY AND SPECIFICITY; STROKE; TIME FACTORS; VASCULAR CELL ADHESION MOLECULE-1; VON WILLEBRAND FACTOR;

EID: 70649111461     PISSN: 08995885     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccell.2009.07.010     Document Type: Review

References (31)

1. Lloyd-Jones D., Adams H.P., Carnethon M., et al., American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2009 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119 (2009) e51-e66
2. Gonzalez R.G. Imaging guided acute ischemic stroke therapy: from "time to brain" to "physiology is brain". AJNR Am J Neuroradiol 27 4 (2006) 728-735
3. McGruder H.F., Croft J.B., and Zheng Z.J. Characteristics of an "ill defined" diagnosis for stroke: opportunities for improvement. Stroke 37 3 (2006) 781-789
4. Whiteley W., Tsend M., and Sandercock P. Blood biomarkers in the diagnosis of ischemic stroke: a systematic review. Stroke 39 10 (2008) 2902-2909
5. Atkinson A.J., Colburn W.A., DeGruttola V.G., et al., Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69 3 (2001) 89-95
6. Vasan R.S. Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation 113 19 (2006) 2335-2362
7. Laskowitz D.T., Kasner S.E., Saver J., et al., Brain Study Group. Clinical usefulness of a biomarker-based diagnostic test for acute stroke. The Biomarker Rapid Assessment in Ischemic Injury (BRAIN) Study. Stroke 40 1 (2009) 1-11
8. Lo E.H., Dalkara T., and Moskowitz M.A. Mechanisms, challenge, and opportunities in stroke. Nat Rev Neurosci 4 5 (2003) 399-415
9. Department of Health and Human Services, Centers for Disease Control and Prevention. First-ever county level report on stroke hospitalizations. CDC Press Release. Available at: (March 28, 2008). http://www.cdc.gov/media/pressrel/2008/r0803.htm Accessed November 27, 2008
10. Gusev E., and Skvortsova V.I. Brain ischemia (2003), Plenum Publishers, New York p. 39-93
11. Huang J., Urvashi M., Upadhyay B.S., et al. Inflammation in stroke and focal cerebral ischemia. Surg Neurol 66 3 (2006) 232-245
12. Wang Q., Tang X.N., and Yenari M.A. The inflammatory response in stroke. J Neuroimmunol 184 1-2 (2007) 53-68
13. Rodrigues-Yanez M., and Castillo J. Role of inflammatory markers in brain ischemia. Curr Opin Neurol 21 3 (2008) 353-357
14. Zheng Z., and Yenari M. Post-ischemic inflammation: molecular mechanisms and therapeutic implications. Neurol Res 26 8 (2004) 884-892
15. Del Zoppo G.J., Schmid-Schonbein G.W., Mori E., et al. Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke 22 10 (1991) 1276-1283
16. Del Zoppo G.J. Microvascular responses to cerebral ischemia/inflammation. Ann N Y Acad Sci 823 (1997) 132-147
17. Castillo J., and Rodriguez I. Biochemical changes and inflammatory response as markers for brain ischemia: molecular markers of diagnostic utility and prognosis in human clinical practice. Cerebrovasc Dis 17 Suppl 1 (2004) 7-18
18. Lynch J.R., Blessing R., White W.D., et al. Novel diagnostic test for acute stroke. Stroke 35 1 (2004) 57-63
19. Reynolds M.A., Kirchick H.J., Dahlen J.R., et al. Early biomarkers of stroke. Clin Chem 49 10 (2003) 1733-1739
20. Montaner J., Rovira A., Mollina C.A., et al. Plasmatic level of neuroinflammatory markers predict the extent of diffusion-weighted image lesions in hyperacute stroke. J Cereb Blood Flow Metab 23 12 (2003) 1403-1407
21. Del Zoppo G.J., and Hallenbeck J.M. Advances in the vascular pathophysiology of ischemic stroke. Thromb Res 98 3 (2000) V73-V81
22. Montaner J. Stroke biomarkers: can they help us to guide stroke thrombolysis?. Drug News Perspect 19 9 (2006) 523-532
23. Montaner J., Molina C.A., Monasterio J., et al. Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. Circulation 107 4 (2003) 598-603
24. The NINDS t-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke 28 11 (1997) 2109-2118
25. Hamann G.F., Okada Y., Fitridge R., et al. Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion. Stroke 26 11 (1995) 2120-2126
26. Montaner J., Alvariz-Sabin J., Molina C.A., et al. Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke. Stroke 32 12 (2001) 2762-2767
27. Castellanos M., Leira R., Serena J., et al. Plasma metalloproteinase-9 concentration predicts hemorrhage transformation in acute ischemic stroke. Stroke 34 1 (2003) 40-46
28. Lapchak P.A., Chapman D., and Zivin J.A. Metalloproteinase inhibition reduced thrombolytic (tissue plasminogen activation)-induced hemorrhage after thromboembolic stroke. Stroke 31 12 (2000) 3034-3040
29. Sumii T., and Lo E.H. Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats. Stroke 33 3 (2002) 831-836
30. Jensen M.B., Chacon M.R., Sattin J.A., et al. The promise and potential pitfalls of serum biomarkers for ischemic stroke and transient ischemic attack. Neurologist 14 4 (2008) 243-246
31. Laskowitz D.T., Blessing R., Floyd J., et al. Panel of biomarkers predict stroke. [abstract]. Ann N Y Acad Sci 1053 (2005) 30